Correlation Between Cytosorbents Crp and Vivos Therapeutics

Can any of the company-specific risk be diversified away by investing in both Cytosorbents Crp and Vivos Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cytosorbents Crp and Vivos Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cytosorbents Crp and Vivos Therapeutics, you can compare the effects of market volatilities on Cytosorbents Crp and Vivos Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cytosorbents Crp with a short position of Vivos Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cytosorbents Crp and Vivos Therapeutics.

Diversification Opportunities for Cytosorbents Crp and Vivos Therapeutics

-0.36

Correlation Coefficient

Cytosorbents Crp  Vivos Therapeutics

Very good diversification

The 3 months correlation between Cytosorbents and Vivos is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Cytosorbents Crp and Vivos Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vivos Therapeutics and Cytosorbents Crp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cytosorbents Crp are associated (or correlated) with Vivos Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vivos Therapeutics has no effect on the direction of Cytosorbents Crp i.e., Cytosorbents Crp and Vivos Therapeutics go up and down completely randomly.

Pair Corralation between Cytosorbents Crp and Vivos Therapeutics

Given the investment horizon of 90 days Cytosorbents Crp is expected to under-perform the Vivos Therapeutics. In addition to that, Cytosorbents Crp is 1.25 times more volatile than Vivos Therapeutics. It trades about -0.11 of its total potential returns per unit of risk. Vivos Therapeutics is currently generating about 0.17 per unit of volatility. If you would invest  293.00  in Vivos Therapeutics on September 21, 2024 and sell it today you would earn a total of  173.00  from holding Vivos Therapeutics or generate 59.04% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Cytosorbents Crp  vs.  Vivos Therapeutics

Cytosorbents Crp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Cytosorbents Crp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Vivos Therapeutics

Risk-Adjusted Performance

13 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Vivos Therapeutics are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively conflicting basic indicators, Vivos Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Cytosorbents Crp and Vivos Therapeutics

The main advantage of trading using opposite Cytosorbents Crp and Vivos Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cytosorbents Crp position performs unexpectedly, Vivos Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vivos Therapeutics will offset losses from the drop in Vivos Therapeutics' long position.

The idea behind Cytosorbents Crp and Vivos Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.